Skip to content
Tailored study design & rapid initiation

Explore our broad portfolio of translational kidney disease models

Gubra offers a wide range of preclinical models of chronic kidney disease (CKD), diabetic kidney disease (DKD), and acute kidney injury (AKI). Our automated AI-based histology pipeline and clinically relevant biomarkers enable effective, accurate and objective analysis of drug effects.

Meet us at the ASN Kidney Week 2026

Download the Posters


Gubra will participate in ASN Kidney Week 2026, taking place 21–25 October in Denver, Colorado. Visit Gubra at booth #249. Download our scientific posters ahead of the conference to explore our latest preclinical kidney research and discover how our translational kidney disease models and advanced technologies can support your drug development programme.

Standard Kidney Study Outlines

“

We are experts in bridging preclinical and clinical development.


MICHAEL CHRISTENSEN, Head of Scientific Sales

Michael´s primary focus is to offer his insight into preclinical drug evaluation within chronic kidney disease. He has a decade of experience from working with preclinical models of kidney disease and knows the strengths and weaknesses of the various models and can guide in choosing the right model for the specific project.

Video: Visualizing cyst formation in a rat model of polycystic kidney disease.

Let’s meet at ASN Kidney Week 2026

Contact us

Gubra

Hørsholm Kongevej 11B
2970 Hørsholm
Denmark

+45 3152 ­2650

Back To Top